2-120042090-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_020909.4(EPB41L5):c.265A>G(p.Met89Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000301 in 1,461,138 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020909.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000438 AC: 11AN: 251068 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461138Hom.: 0 Cov.: 30 AF XY: 0.0000289 AC XY: 21AN XY: 726874 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.265A>G (p.M89V) alteration is located in exon 3 (coding exon 2) of the EPB41L5 gene. This alteration results from a A to G substitution at nucleotide position 265, causing the methionine (M) at amino acid position 89 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at